# Candel Therapeutics, Inc.: Form 8-K, filed Jun 24, 2026

- Company: [Candel Therapeutics, Inc.](/companies/cadl.md) (CIK 1841387)
- Form: 8-K
- Filed: 2026-06-24
- Accepted by EDGAR: Jun 24, 2026, 16:24 ET
- Period: 2026-06-23
- Accession: 0001841387-26-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1841387/000184138726000009/cadl-20260623.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841387/000184138726000009/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841387/000184138726000009/cadl-20260623.htm

Filed Jun 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001841387-26-000009. Last ingested by Listed: Nov 13, 2026, 16:13 ET. No prices; not investment advice.
